Sensitivity of Indirect Metrics for Assessing “Rate” in Bioequivalence Studies—Moving the “Goalposts” or Changing the “Game”
- 1 November 1994
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 83 (11) , 1554-1557
- https://doi.org/10.1002/jps.2600831107
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Evaluation of Different Indirect Measures of Rate of Drug Absorption in Comparative Pharmacokinetic StudiesJournal of Pharmaceutical Sciences, 1994
- In vitro/in vivo correlations in biopharmaceutics: scientific and regulatory implicationsEuropean Journal of Drug Metabolism and Pharmacokinetics, 1993
- Bioequivalence revisitedStatistics in Medicine, 1992
- An Alternative Approach for Assessment of Rate of Absorption in Bioequivalence StudiesPharmaceutical Research, 1992
- International Harmonization and Consensus DIA Meeting on Bioavailability and Bioequivalence Testing Requirements and StandardsDrug Information Journal, 1991
- Dse and Limitations of the Truncated Area Under the Curve in Bioequivalence TestingClinical Research Practices and Drug Regulatory Affairs, 1990
- Power Analyses of Moment Analysis Parameter in Bioequivalence TestsJournal of Pharmaceutical Sciences, 1989
- Application of Moment Analysis in Assessing Rates of Absorption for Bioequivalency StudiesJournal of Pharmaceutical Sciences, 1987
- Comparison of Statistical Moment Parameters to Cmax and tmax for Detecting Differences in In Vivo Dissolution RatesJournal of Pharmaceutical Sciences, 1985
- Bioavailability, Clinical Effectiveness, and the Public InterestPharmacology, 1972